Literature DB >> 3973270

Intraaortic balloon counterpulsation as a temporary support measure in decompensated critical aortic stenosis.

E D Folland, A J Kemper, S F Khuri, M Josa, A F Parisi.   

Abstract

Intraaortic balloon counterpulsation was instituted in two adult patients whose condition was rapidly deteriorating because of critical decompensated valvular aortic stenosis. The acute hemodynamic effect of counterpulsation in these patients was compared with the effect of counterpulsation in three control patients with unstable angina and no aortic valve disease. Augmentation of aortic diastolic pressure was similar in both groups; however, in contrast to the patients with unstable angina, the patients with aortic stenosis had no decrease in left ventricular systolic pressure. Counterpulsation resulted in an increase in the transvalvular pressure gradient, which was associated with a slight increase in stroke volume. In both patients with aortic stenosis, the institution of counterpulsation resulted in marked clinical improvement, which facilitated successful valve replacement surgery. The benefit from counterpulsation in critically decompensated aortic stenosis appears to be derived almost entirely from augmentation of the diastolic coronary filling gradient. The improvement that results from counterpulsation suggests that ischemia is the major cause of decompensation.

Entities:  

Mesh:

Year:  1985        PMID: 3973270     DOI: 10.1016/s0735-1097(85)80399-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

1.  Stenosis of the bicuspid aortic valve with systemic lupus erythematosus.

Authors:  Masaru Yoshikai; Junichi Muraya; Hiroya Fujita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-01

Review 2.  [Patients in the intensive care unit with valvular diseases].

Authors:  A Geppert
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-15       Impact factor: 0.840

Review 3.  IABP: history-evolution-pathophysiology-indications: what we need to know.

Authors:  H Parissis; V Graham; S Lampridis; M Lau; G Hooks; P C Mhandu
Journal:  J Cardiothorac Surg       Date:  2016-08-04       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.